Skip to content

Cencora COR Alliance Healthcare — Revenue

Other product segments

Animal Health
$1.44B+5.3%
Other Healthcare Solutions
$1.05B+13.5%
Other non-strategic businesses
$619.78M+4.5%

Similar metrics at other companies

Pfizer logo
PFETotal Alliance revenues — Alliance revenues
$2.34B+10.7%
Pfizer logo
PFEAlliance revenues
$2.34B+10.7%
Bristol-Myers Squibb logo
BMYAlliance revenues — Total Revenues
$94M+6.8%
AMN Healthcare logo
AMNAllied staffing — Revenue
$151.29M+2.6%
Bristol-Myers Squibb logo
BMYAlliance and other revenues — Total Revenues
$321M+1.9%
Fortive logo
FTVAdvanced Healthcare Solutions — Total sales
$326.2M+7.9%

Other financials

Income statement

See full
Revenue$78.4B+3.8%
Gross profit$3.6B+17.3%
Operating income$1.1B+10.3%
Net income$1.6B+129%
EPS (diluted)$8.40+128%

Balance sheet

See full
Cash & equivalents$2.2B+10.0%
Total debt$12.2B+71.9%
Total equity$3.4B+235%
Total assets$81.7B+14.7%

Cash flow

See full
Operating cash flow-$2.3B+15.2%
CapEx$165.6M+28.3%
Free cash flow-$2.4B+14.2%

Valuation

See full
Market cap$55.83B-1.9%
Enterprise value$65.84B+6.1%
P/E15.5×+3.1×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.4pp
Operating margin0.8%0.0pp
Net margin0.6%-0.1pp
FCF margin1.1%+1.0pp

Returns & leverage

See full
Return on equity130.6%-99.8pp
Debt / equity3.6×-3.4×
Current ratio0.9×+0.1×

Where this comes from

Reported directly by Cencora in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Cencora’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cencora's alliance healthcare — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cencora's alliance healthcare — revenue?
Cencora (COR) reported alliance healthcare — revenue of $6.52B in Q1 2026.
What does alliance healthcare — revenue mean?
This metric represents the total gross sales generated by the Alliance Healthcare segment, which focuses on pharmaceutical wholesale and distribution services primarily within European markets. It captures the value of pharmaceutical products, medical devices, and healthcare solutions sold to pharmacies, hospitals, and other healthcare providers. As a key component of the company's international footprint, this revenue stream reflects the scale and market penetration of the firm's global distribution network.